| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17:42 | Ardena Completes Divestment of Sweden Drug Substance Site to Nanologica | 2 | Contract Pharma | ||
| 12:11 | Veeco und imec entwickeln 300-mm-Prozess für Bariumtitanat in Siliziumphotonik | 1 | evertiq | ||
| 08:20 | Nanologica AB: Nanologica Carries Out Directed Share Issues Of Approx. Sek 13.7 Million In Total, And A Fully Secured Rights Issue Of Approx. Sek 82.5 Million | 172 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 02:18 | Zentek Ltd: Zentek CEO issues letter to shareholders | 1 | Stockwatch | ||
| 00:50 | Anteotech Accelerates Battery and Life Sciences Commercialisation as Capital Raise Extends Runway | 3 | smallcaps.com.au | ||
| Do | Zentek Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Do | California Nanotechnologies Corp.: California Nanotechnologies Announces Q3 2026 Results | 363 | Newsfile | Quarterly revenue of US$392K due to orders being pushed to subsequent quarterAdjusted EBITDA1 loss of US$747K, expected to improve in Q4/FY2026 on higher revenuesVisibility on potential commercial... ► Artikel lesen | |
| Do | Zentek announces strategic reset to focus on three core platforms | 1 | Investing.com | ||
| Do | DOTZ NANO LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| Do | Zentek Ltd.: Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan | 247 | Newsfile | Guelph, Ontario--(Newsfile Corp. - January 29, 2026) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") today announced that it has issued a letter to shareholders outlining a... ► Artikel lesen | |
| Do | ANTEOTECH LTD: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| Do | Ardena Holding NV.: Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica | 320 | GlobeNewswire (Europe) | Ghent, Belgium, 29th January 2026 - Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of... ► Artikel lesen | |
| Do | NEXSEN LIMITED: Quarterly Report - Q2 FY26 | - | ASX | ||
| Do | Quantum Base Hldgs - Interim Results | - | RNS | ||
| Do | REGION GROUP: Taxation Components RGN Half Year Distribution December 2025 | 1 | ASX | ||
| Mi | VEECO INSTRUMENTS INC - 8-K, Current Report | 1 | SEC Filings | ||
| Mi | Veeco and imec develop 300mm-compatible process to enable integration of barium titanate on silicon photonics | 3 | Semiconductor Today | ||
| Mi | SMOLTEK NANOTECH HOLDING AB: Smoltek Hydrogen admitted into Swedish-German Cleantech Platform 2026 - strengthens position in Europe's leading hydrogen market | 4 | Cision News | ||
| Di | ANTEOTECH LTD: Appointment of Interim CFO and Company Secretary | - | ASX | ||
| Di | AnteoTech Raises $3.5m for Global Commercialisation of Life Sciences and Advanced Battery Technologies | 3 | smallcaps.com.au |
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| ZENTEK | 2 | 3 | 0,00 % | Zentek Ltd.: Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan | Guelph, Ontario--(Newsfile Corp. - January 29, 2026) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") today announced that it has issued a letter to shareholders outlining a... ► Artikel lesen | ||
| NANOLOGICA | 2 | - | 0,00 % | Nanologica AB: Nanologica Carries Out Directed Share Issues Of Approx. Sek 13.7 Million In Total, And A Fully Secured Rights Issue Of Approx. Sek 82.5 Million | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | ||
| ANTEOTECH | 1 | 3 | - | Anteotech Accelerates Battery and Life Sciences Commercialisation as Capital Raise Extends Runway | |||
| VEECO INSTRUMENTS | 1 | 2 | -1,46 % | Veeco und imec entwickeln 300-mm-Prozess für Bariumtitanat in Siliziumphotonik | |||
| ONTO INNOVATION | - | 6 | -3,91 % | Beyond The Numbers: 8 Analysts Discuss Onto Innovation Stock | |||
| NANOFOCUS | - | 3 | +1,08 % | Nanofocus: Aus in München und Berlin | Im November hat eine außerordentliche Hauptversammlung von Nanofocus beschlossen, die Aktien der Minderheitsaktionäre auf die Carl Mahr Holding zu übertragen. Dies ist der Hauptaktionär der Oberhausener.... ► Artikel lesen | ||
| FORMYCON | - | 3 | +0,44 % | EQS-DD: Formycon AG: Active Ownership Fund SICAV SIF SCS, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
14.01.2026 / 19:31... ► Artikel lesen | ||
| SOLESENCE | - | 2 | +3,03 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | ||
| RIBER | - | 2 | +6,34 % | Riber receives a new order from Japan for MBE 6000 to scale Quantum Dot Laser production for Datacom | Riber receives a new order from Japan for MBE 6000 to scale Quantum Dot Laser production for Datacom. Bezons (France), 19 January 2026 - 8:00 am (CET) - RIBER, a global market leader in molecular beam... ► Artikel lesen | ||
| FENDX TECHNOLOGIES | - | 2 | +6,96 % | FendX Technologies Inc.: FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents | Vancouver, British Columbia--(Newsfile Corp. - January 22, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen |
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| FORMYCON AG | 23,000 | 40,50 | +76 % | 3 | - | - |